Arcellx, Inc. Files 8-K Report

Ticker: ACLX · Form: 8-K · Filed: Nov 5, 2024 · CIK: 1786205

Arcellx, INC. 8-K Filing Summary
FieldDetail
CompanyArcellx, INC. (ACLX)
Form Type8-K
Filed DateNov 5, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: 8-K, SEC Filing, Corporate Update

TL;DR

Arcellx filed an 8-K on Nov 5th. Standard update.

AI Summary

Arcellx, Inc. filed an 8-K on November 5, 2024, reporting other events and financial statements. The company, incorporated in Delaware, is involved in biological products and has its principal executive offices in Redwood City, California.

Why It Matters

This filing indicates Arcellx, Inc. is providing updates on its corporate activities and financial status to the SEC, which is important for investors to monitor.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K report, which typically contains updates on corporate events and financial information.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Arcellx, Inc.?

The 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of November 5, 2024.

When was Arcellx, Inc. incorporated and where are its principal executive offices located?

Arcellx, Inc. was incorporated in Delaware and its principal executive offices are located at 800 Bridge Parkway, Redwood City, CA 94065.

What is the Commission File Number and IRS Employer Identification Number for Arcellx, Inc.?

The Commission File Number is 001-41259 and the IRS Employer Identification No. is 47-2855917.

What is the SIC code and industry classification for Arcellx, Inc.?

The Standard Industrial Classification (SIC) code is 2836, and the industry is 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.

What is the fiscal year end for Arcellx, Inc.?

The fiscal year end for Arcellx, Inc. is December 31 (1231).

Filing Stats: 500 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-11-05 09:17:00

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated November 5, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Arcellx, Inc. Date: November 5, 2024 By: /s/ Rami Elghandour Rami Elghandour Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing